Q1 2021
QUARTERLY FINANCIAL REPORT
At a Glance | Fresenius Share | Management Report | Financial Statements | Notes | Financial Calendar/Contact | Table of contents |
TABLE OF CONTENTS
3 | Fresenius Group figures at a glance | 6 | Management Report | 20 | Rating | |
6 | Health care industry | 20 | Virtual Annual General Meeting | |||
8 | Results of operations, financial position, assets and liabilities | 21 | Outlook 2021 | |||
5 | Fresenius share | 8 | Sales | 24 | Reconciliation table | |
9 | Earnings | 24 | Estimated COVID-19 effects | |||
10 | Reconciliation | |||||
10 | Investments | |||||
10 | Cash flow | 25 | Consolidated financial statements | |||
10 | Asset and liability structure | 25 | Consolidated statement of income | |||
11 | Business segments | 26 | Consolidated statement of comprehensive income | |||
11 | Fresenius Medical Care | 27 | Consolidated statement of financial position | |||
13 | Fresenius Kabi | 28 | Consolidated statement of cash flows | |||
15 | Fresenius Helios | 30 | Consolidated statement of changes in equity | |||
17 | Fresenius Vamed | 32 | Consolidated segment reporting first quarter of 2021 | |||
19 | Employees | |||||
19 | Changes to the Management Board | |||||
19 | Changes to the Supervisory Board | 33 | Notes | |||
proposal to the AGM | ||||||
19 | Research and development | |||||
20 | Opportunities and risk report | 55 | Financial Calendar | |||
20 | Subsequent events |
Fresenius Quarterly Financial Report 1st Quarter 2021
2
At a Glance | Fresenius Share | Management Report | Financial Statements | Notes | Financial Calendar/Contact |
FRESENIUS GROUP FIGURES AT A GLANCE
Fresenius is a global health care group providing products and services for dialysis, hospitals, and outpatient medical care. In addition, Fresenius focuses on hospital operations. We also manage projects and provide services for hospitals and other health care facilities. In 2020, Group sales were €36.3 billion. As of March 31, 2021, more than 310,000 employees have dedicated themselves to the service of health in about 100 countries worldwide.
SALES, EARNINGS, AND CASH FLOW
-
in millions Sales
EBIT before special items Net income reported1
Net income before special items1 Earnings per share in € reported1 Earnings per share in € before special items1 Operating cash flow
Table of contents
Growth | |||||||
in constant | |||||||
Q1 / 2021 | Q1 / 2020 | Growth | currency | ||||
8,984 | 9,135 | -2% | 3% | ||||
1,006 | 1,125 | -11% | -6% | ||||
435 | 459 | -5% | -1% | ||||
435 | 465 | -6% | -2% | ||||
0.78 | 0.82 | -5% | -1% | ||||
0.78 | 0.83 | -6% | -2% | ||||
652 | 878 | -26% | -- |
Fresenius Quarterly Financial Report 1st Quarter 2021
1 | Net income attributable to shareholders of Fresenius SE & Co. KGaA | 3 |
At a Glance | Fresenius Share | Management Report | Financial Statements | Notes | Financial Calendar/Contact | Table of contents |
BALANCE SHEET AND INVESTMENTS
€ in millions | March 31, | December 31, | ||||||||
2021 | 2020 | Change | ||||||||
Total assets | 68,966 | 66,646 | 3% | |||||||
Non-current assets | 52,273 | 50,874 | 3% | |||||||
Equity | 27,514 | 26,023 | 6% | |||||||
Net debt | 24,631 | 24,076 | 2% | |||||||
Investments and acquisitions (Q1 2021 / Q1 2020) | 533 | 959 | -44% | |||||||
RATIOS | ||||||||||
Q1 / 2021 | Q1 / 2020 | |||||||||
EBITDA margin1 | 18.1% | 19.2% | ||||||||
EBIT margin1 | 11.2% | 12.3% | ||||||||
Depreciation and amortization in % of sales1 | ||||||||||
6.9% | 6.9% | |||||||||
Operating cash flow in % of sales | 7.3% | 9.6% | ||||||||
Equity ratio (March 31 / December 31) | 39.9% | 39.0% | ||||||||
Net debt / EBITDA1, 2 (March 31 / December 31) | ||||||||||
3.52 | 3.44 | |||||||||
Fresenius Quarterly Financial Report 1st Quarter 2021
1 | Before special items | 4 |
2 | At LTM average exchange rates for both net debt and EBITDA; pro forma closed acquisitions / divestitures |
At a Glance | Fresenius Share | Management Report | Financial Statements | Notes | Financial Calendar/Contact | Table of contents |
FRESENIUS-SHARE
Since the beginning of the year, the Fresenius share has moved sideways and closed the first quarter of 2021 at a price of €37.98.
RELATIVE SHARE PRICE PERFORMANCE VS. DAX | 31.12.2020 = 100 |
110 | |
105 | |
100 | |
95 | |
90 |
31.12.2020 | 31.01.2021 | 28.02.2021 | 31.03.2021 | |||
Fresenius share | DAX | |||||
KEY DATA OF THE FRESENIUS SHARE
Q1 / 2021 | 2020 | Growth | |||||
Number of shares (March 31 / December 31) | 557,541,659 | 557,540,909 | 0% | ||||
Stock exchange quotation1 in € | |||||||
High | 40.10 | 50.32 | -20% | ||||
Low | 34.57 | 25.66 | 35% | ||||
Period-end quotation closing price in € | 37.98 | 37.84 | 0% | ||||
Ø Trading volume (number of shares per trading day) | 1,802,020 | 2,085,926 | -14% | ||||
Market capitalization2 in million € (March 31 / December 31) | |||||||
21,175 | 21,097 | 0% | |||||
Earnings per share in €3 | |||||||
0.78 | 3.22 | -- |
- Xetra closing price on the Frankfurt Stock Exchange
- Total number of ordinary shares multiplied by the respective Xetra period-end quotation on the Frankfurt Stock Exchange
3 Net income attributable to shareholders of Fresenius SE & Co. KGaA; before special items
FIRST QUARTER 2021
The COVID-19 pandemic marked the first three months of 2021 with persistently high infection rates and the spread of virus mutations slowing down the recovery of the global economy. More stringent containment measures imposed by governments led to a setback in economic activity and employment. Despite a gradual vaccination coverage of the population, the further development of the COVID-19 pandemic and the overall global economy remains uncertain. The capital markets and global investment levels remained stable, benefitting from economic stimulus measures taken by governments and favorable financing conditions.
According to the ECB's current forecast, the economy in the euro zone will grow by 4.0% this year. The ECB left its key interest rate unchanged at 0.00% during its March meeting.
The Federal Reserve's latest forecast projects the U.S. economy to grow by 6.5% in 2021. The U.S. Federal Reserve did not change the existing interest rates corridor of 0% to 0.25% at its March meeting.
Within this economic environment, the DAX increased by 9% in the first three months of 2021 to 15,008 points. The Fresenius share closed at €37.98 on March 31, 2021, almost unchanged over the same period.
Fresenius Quarterly Financial Report 1st Quarter 2021
5
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original document
- Permalink
Disclaimer
Fresenius SE & Co. KGaA published this content on 07 May 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 07 May 2021 15:55:04 UTC.